TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6989292

Group type: EXPERIMENTAL
Intervention: (+)-ketamine (PK), 1 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: (−)-ketamine (MK), 3 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: racemic ketamine (RK), 2 mg/kg
Number of subjects: 60
Study: 31206433

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (2-3 µg·kg) administered approximately 1 hour before MRI
Number of subjects: 50
Study: 30621614

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (titrated doses of 20 to 60 μg following a 3 h on + 1 h off regimen up to a maximum of 24 h)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (25 μg every 4 h up to a maximum of 24 h)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Vaginal dinoprostone (10 mg via controlled-release vaginal insert for up to 24 h)
Number of subjects: 3
Study: 28656353

Group type: EXPERIMENTAL
Intervention: Low tidal volume with PEEP (TV, 5-7 ml/kg; PEEP, 4-6 cmH2O)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional group (TV, 8-10 ml/kg; PEEP, 0 cmH2O)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 24491348

Group type: EXPERIMENTAL
Intervention: Twice weekly structured exercise training (ET) for 12 weeks
Number of subjects: 106

Group type: COMPARATOR
Intervention: Exercise advice (control)
Number of subjects: 106
Study: 23926207

Group type: EXPERIMENTAL
Intervention: Visit-to-visit variability in systolic blood pressure (SBP)
Number of subjects: 8811

Group type: EXPERIMENTAL
Intervention: Maximum systolic blood pressure (SBP)
Number of subjects: 8811
Study: 20455192

Group type: EXPERIMENTAL
Intervention: Swivel seat
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fixed seat
Number of subjects: 10
Study: 18363576

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA)
Number of subjects: 414

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 414
Study: 16404566

Group type: EXPERIMENTAL
Intervention: Direct radiography (DR) at 50% dose
Number of subjects: 50

Group type: COMPARATOR
Intervention: Computed radiography (CR) at regular dose
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Direct radiography (DR) at regular dose
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Direct radiography (DR) at reduced dose
Number of subjects: 50
Study: 14686266

Group type: EXPERIMENTAL
Intervention: Recreational Music-making (RMM) protocol (6 sessions)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Economic impact analysis
Number of subjects: 112
Study: 11192961

Group type: EXPERIMENTAL
Intervention: Group A - discharged after remission of signs and symptoms
Number of subjects: 167

Group type: COMPARATOR
Intervention: Group B - discharged after improvement but before complete remission of signs and symptoms
Number of subjects: 167
Study: 8832118

Group type: EXPERIMENTAL
Intervention: Explaining conversation rules (I‐don't‐know is acceptable, interviewer cannot help)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (no explanation of conversation rules)
Number of subjects: 114
Study: 1466464

Group type: EXPERIMENTAL
Intervention: 0.1 MAC isoflurane
Number of subjects: 8

Group type: COMPARATOR
Intervention: Carrier gas (control)
Number of subjects: 8
Study: 4045717

Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marketed nicotine gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: New nicotine gum (less side-effects)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gum (with more side-effects)
Number of subjects: 0
Study: 31078351

Group type: EXPERIMENTAL
Intervention: Participants in the DANAMI-3 trial (n = 179)
Number of subjects: 796

Group type: COMPARATOR
Intervention: Eligible excluded (n = 144)
Number of subjects: 796

Group type: COMPARATOR
Intervention: Ineligible excluded (n = 472)
Number of subjects: 796

Group type: COMPARATOR
Intervention: Eligible non-screened (n = 154)
Number of subjects: 796

Group type: COMPARATOR
Intervention: Ineligible non-screened (n = 154)
Number of subjects: 796
Study: 28752433

Group type: EXPERIMENTAL
Intervention: ANF-RHO (5-50 μg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ANF-RHO (5-30 μg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ANF-RHO (50 μg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pegfilgrastim (6 mg, equivalent to 80-100 μg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ANF-RHO
Number of subjects: 0
Study: 28101914

Group type: EXPERIMENTAL
Intervention: Low cortisol (300 ng mL-1)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: High cortisol (1,000 ng mL-1)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control (0 ng mL-1)
Number of subjects: 3
Study: 25252663

Group type: EXPERIMENTAL
Intervention: Passive tactile stimulation (two daily sessions of 30 minutes each for six months)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Passive tactile stimulation
Number of subjects: 8
Study: 22980174

Group type: EXPERIMENTAL
Intervention: Maintaining apical patency with a no. 10 K-file 1 mm beyond the working length (WL)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No patency (NP)
Number of subjects: 43
Study: 20181361

Group type: EXPERIMENTAL
Intervention: LI160 (600 mg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 17570881

Group type: EXPERIMENTAL
Intervention: Case management group
Number of subjects: 67

Group type: COMPARATOR
Intervention: Usual-care group
Number of subjects: 67
Study: 17681347

Group type: EXPERIMENTAL
Intervention: CoQ10 supplementation (100mg/day)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 15036741

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (4ml/kg, 1.8meq./kg over 3-5min)
Number of subjects: 55

Group type: COMPARATOR
Intervention: 5% dextrose (4ml/kg at similar rate)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 55

Group type: COMPARATOR
Intervention: 5% dextrose
Number of subjects: 55
Study: 11212131

Group type: EXPERIMENTAL
Intervention: IFNbeta‐1a (Avonex)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Change in BPF
Number of subjects: 160
Study: 9054795

Group type: EXPERIMENTAL
Intervention: Social skills training for deficit syndrome
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Social skills training for nondeficit negative symptoms
Number of subjects: 6
Study: 8347969

Group type: EXPERIMENTAL
Intervention: Diagnostic epidural blockade with local anaesthetic
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline injection into the epidural space
Number of subjects: 100
Study: 3519043

Group type: EXPERIMENTAL
Intervention: Urapidil 60 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Urapidil 90 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Urapidil 120 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31340204

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Not applicable (control group is OMT)
Number of subjects: 117
Study: 29898059

Group type: EXPERIMENTAL
Intervention: Ketoprofen 200 mg + Omeprazole 20 mg (once daily - q.d.)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ketoprofen 100 mg (twice daily - b.i.d.)
Number of subjects: 50
Study: 27701019

Group type: EXPERIMENTAL
Intervention: Payment Card (PC)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Structured Haggling (SH)
Number of subjects: 376
Study: 22006639

Group type: EXPERIMENTAL
Intervention: Scopolamine (0.4 mg, i.v.)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 15
Study: 19459752

Group type: EXPERIMENTAL
Intervention: Camel milk (500 mL daily)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual management (diet, exercise, and insulin)
Number of subjects: 54
Study: 17257536

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (1.0 ml)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Triamcinolone acetonide (1.0 ml)
Number of subjects: 37
Study: 15170529

Group type: EXPERIMENTAL
Intervention: Respiratory physiotherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Suction
Number of subjects: 100
Study: 11666117

Group type: EXPERIMENTAL
Intervention: TTFCA (tablets, 60 mg, twice daily for 8 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9840297

Group type: EXPERIMENTAL
Intervention: Enzyme-linked immunosorbent assay (ELISA) for detecting serum anti-H. pylori immunoglobulin G antibodies
Number of subjects: 249
Study: 7988248

Group type: EXPERIMENTAL
Intervention: Postoperative mediastinal radiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 0
Study: 2928037

Group type: EXPERIMENTAL
Intervention: 1 gm/kg alcohol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 0.5 gm/kg alcohol
Number of subjects: 48
Study: 31784559

Group type: EXPERIMENTAL
Intervention: L-DOPA treatment
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 87
Study: 28918120

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MMWR), 12-session program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MMWR)
Number of subjects: 0
Study: 24603938

Group type: EXPERIMENTAL
Intervention: Exercise training (n=14, 54-60 training sessions)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (n=9)
Number of subjects: 23
Study: 23707162

Group type: EXPERIMENTAL
Intervention: Attenuated Listeria monocytogenes vaccine strain with cholera toxin adjuvant
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 22027793

Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin
Number of subjects: 65

Group type: COMPARATOR
Intervention: 40 mg simvastatin
Number of subjects: 65
Study: 20008225

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy as post-remission therapy
Number of subjects: 300000

Group type: EXPERIMENTAL
Intervention: Allogeneic transplantation
Number of subjects: 300000

Group type: EXPERIMENTAL
Intervention: New and targeted agents
Number of subjects: 300000
Study: 17307760

Group type: EXPERIMENTAL
Intervention: Congruent odor (e.g., strawberry/sweet)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Incongruent odor (e.g., strawberry/sour)
Number of subjects: 14
Study: 15568526

Group type: EXPERIMENTAL
Intervention: Rapid Inflation, Asymmetrical Compression (RIAC) device
Number of subjects: 423

Group type: COMPARATOR
Intervention: Sequential Circumferential Compression Device (SCD)
Number of subjects: 423
Study: 15513239

Group type: EXPERIMENTAL
Intervention: Short lines (1-8 cm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long lines (8-28 cm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard US legal-sized paper background
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doubled width background
Number of subjects: 0
Study: 10962123

Group type: EXPERIMENTAL
Intervention: Late potentials (LP group)
Number of subjects: 101

Group type: COMPARATOR
Intervention: NLP group
Number of subjects: 101

Group type: COMPARATOR
Intervention: NLP patients
Number of subjects: 101
Study: 9347373

Group type: EXPERIMENTAL
Intervention: Intratracheal furosemide (0.5 mg/kg)
Number of subjects: 12
Study: 8478839

Group type: EXPERIMENTAL
Intervention: Omentoplasty (n = 15)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Introflexion (n = 18)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Combination of both (n = 10)
Number of subjects: 43
Study: 3748681

Group type: EXPERIMENTAL
Intervention: Radiant warmer
Number of subjects: 13
Study: 31754836

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham irradiation
Number of subjects: 0
Study: 29329559

Group type: EXPERIMENTAL
Intervention: Structured process to simplify medication administration using the Medication Regimen Simplification Guide for Residential Aged Care.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Routine care (comparison group).
Number of subjects: 8
Study: 27010092

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 121

Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKA)
Number of subjects: 121
Study: 24994546

Group type: EXPERIMENTAL
Intervention: Endeavor zotarolimus-eluting stent (E-ZES) in premarket trials
Number of subjects: 5650

Group type: COMPARATOR
Intervention: Endeavor zotarolimus-eluting stent (E-ZES) in postmarket trials
Number of subjects: 5650
Study: 22284900

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 21246855

Group type: EXPERIMENTAL
Intervention: Tuina
Number of subjects: 90

Group type: COMPARATOR
Intervention: Taijiquan
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 90
Study: 18423314

Group type: EXPERIMENTAL
Intervention: Barium sulfate/ferumoxsil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Barium sulfate
Number of subjects: 20
Study: 15877756

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) added to autologous bone graft
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-PRP side (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PRP side
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-PRP side
Number of subjects: 30
Study: 12944692

Group type: EXPERIMENTAL
Intervention: Serum gamma glutamyl transpeptidase (GGTP)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Serum lactate dehydrogenase (LDH)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Serum superoxide dismutase (SOD)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (healthy age-matched individuals)
Number of subjects: 25
Study: 10533448

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy after curative resection
Number of subjects: 13

Group type: COMPARATOR
Intervention: Observation following curative resection
Number of subjects: 13
Study: 8740090

Group type: EXPERIMENTAL
Intervention: Radioimmunoassay (RIA) method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gas Chromatographic/Mass Spectrometric method (GC/MS)
Number of subjects: 0
Study: 15278664

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.1 mg.kg(‐1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.2 mg.kg(‐1)
Number of subjects: 20
Study: 6628500

Group type: EXPERIMENTAL
Intervention: Moclobemide 100 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Moclobemide 150 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Chronic treatment with optimal therapeutic dose (100-400 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (for depressive patients)
Number of subjects: 15
Study: 30680643

Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Positioning treatment (control)
Number of subjects: 60
Study: 27391237

Group type: EXPERIMENTAL
Intervention: Group therapy (20 weeks of manualized therapy)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Behavioral Activation and Cognitive Behavioral Analysis System of Psychotherapy interventions
Number of subjects: 58
Study: 25792351

Group type: EXPERIMENTAL
Intervention: General Anaesthesia (GA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Spinal Anaesthesia (SA)
Number of subjects: 60
Study: 23402870

Group type: EXPERIMENTAL
Intervention: γ-tocopherol (γT) supplementation
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: γ-tocopherol (γT) treatment
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (sunflower oil capsule)
Number of subjects: 13
Study: 21165661

Group type: EXPERIMENTAL
Intervention: EEG-neurofeedback (n = 8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo feedback (n = 6)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: EEG-neurofeedback
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo feedback
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: EEG-neurofeedback and Placebo feedback
Number of subjects: 14
Study: 18805066

Group type: EXPERIMENTAL
Intervention: CHARITE artificial disc
Number of subjects: 133

Group type: COMPARATOR
Intervention: BAK cages and iliac crest autograft
Number of subjects: 133
Study: 17277042

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 (BIAsp 30)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Biphasic human insulin 30 (BHI 30)
Number of subjects: 160
Study: 15536455

Group type: EXPERIMENTAL
Intervention: Darusentan 100 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 11973185

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fentanyl (2.5 microg/kg)
Number of subjects: 100
Study: 10387959

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imiquimod 1% cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 0
Study: 8562003

Group type: EXPERIMENTAL
Intervention: Intervention program promoting condom use among sex workers
Number of subjects: 500
Study: 2756914

Group type: EXPERIMENTAL
Intervention: fat‐modified lactoovovegetarian diet (LOV)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: diet with 60% of plant protein replaced with lean meat (LM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: high‐fat diet
Number of subjects: 26
Study: 337176

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Phenytoin (Dilantin)
Number of subjects: 40
Study: 6896301

Group type: EXPERIMENTAL
Intervention: AVC plus tamoxifen (Adriamycin 40 mg/m2 i.v., vincristin 1 mg/m2 i.v. on day 1, cyclophosphamide 200 mg/m2 p.o. on days 3-6, and tamoxifen 20 mg twice daily)
Number of subjects: 84

Group type: COMPARATOR
Intervention: AVC (Adriamycin 40 mg/m2 i.v., vincristin 1 mg/m2 i.v. on day 1, cyclophosphamide 200 mg/m2 p.o. on days 3-6)
Number of subjects: 84
Study: 30587515

Group type: EXPERIMENTAL
Intervention: Aspirin use
Number of subjects: 83749

Group type: COMPARATOR
Intervention: Non-users of aspirin
Number of subjects: 83749

Group type: EXPERIMENTAL
Intervention: All stroke risk in women with prior HDP
Number of subjects: 83749

Group type: EXPERIMENTAL
Intervention: Stroke before age 60 in women with prior HDP
Number of subjects: 83749
Study: 30185394

Group type: EXPERIMENTAL
Intervention: BZF961 500 mg BID for 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BZF961 50 mg QD or BID with ritonavir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BZF961 lower-dose regimens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27003145

Group type: EXPERIMENTAL
Intervention: Large-capacity serrated biopsy forceps with jaw diameter 2.4 mm (SER2)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Large-capacity oval forceps with jaw diameter 2.4 mm (OVL)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Large-capacity serrated biopsy forceps with jaw diameter 2.2 mm (SER1)
Number of subjects: 136
Study: 25286175

Group type: EXPERIMENTAL
Intervention: CIT-S (Culturally Informed Therapy for Schizophrenia), 15 sessions
Number of subjects: 69

Group type: COMPARATOR
Intervention: PSY-ED (Psychoeducation), 3 sessions
Number of subjects: 69
Study: 22818246

Group type: EXPERIMENTAL
Intervention: Individual telephone counseling (n=67)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Group face‐to‐face counseling (n=74)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Mail/control group (n=74)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Face‐to‐face program
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Telephone program
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control program
Number of subjects: 215
Study: 20044810

Group type: EXPERIMENTAL
Intervention: High dose ursodeoxycholic acid
Number of subjects: 124
Study: 16740515

Group type: EXPERIMENTAL
Intervention: Coaching methodology with home visits
Number of subjects: 88

Group type: COMPARATOR
Intervention: Delayed intervention (control group)
Number of subjects: 88
Study: 12582105

Group type: EXPERIMENTAL
Intervention: Syndromic management for treating STIs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Global guidelines for syndromic management
Number of subjects: 0
Study: 11202589

Group type: EXPERIMENTAL
Intervention: Selective screening for AAA based on risk factors (current smokers)
Number of subjects: 2755

Group type: EXPERIMENTAL
Intervention: General screening of half the male population aged 65‐83 years
Number of subjects: 2755
Study: 9119416

Group type: EXPERIMENTAL
Intervention: Sickle cell disease (HbSS)
Number of subjects: 2570

Group type: EXPERIMENTAL
Intervention: Sickle cell gene carriers (HbAS)
Number of subjects: 2570

Group type: EXPERIMENTAL
Intervention: Mean fetal hemoglobin in sickle cell disease
Number of subjects: 2570
Study: 8447522

Group type: EXPERIMENTAL
Intervention: Desferrioxamine B
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 3533087

Group type: EXPERIMENTAL
Intervention: Suprofen 300 mg suppositories, rectally, t.i.d., for 10 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 28674135

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention consisting of education and advice about the benefits of weight loss and physical activity, and the Australian New South Wales Get Healthy Service.
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group (original cohort)
Number of subjects: 280
Study: 26496648

Group type: EXPERIMENTAL
Intervention: Paromomycin Intramuscular Injection (PMIM) at 11 mg/kg once daily for 21 days
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Paromomycin Intramuscular Injection (PMIM)
Number of subjects: 120
Study: 23392475

Group type: EXPERIMENTAL
Intervention: Self-motion perception training (3,360 practice trials over 12 days in Experiment 1 and 6 days in Experiment 2)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Self-motion perception training with visual input (Experiment 3)
Number of subjects: 11
Study: 21852344

Group type: EXPERIMENTAL
Intervention: Modified 'You Make the Difference' programme over six weekly sessions
Number of subjects: 301

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 301
Study: 20027367

Group type: EXPERIMENTAL
Intervention: Tenoten (anxiolytic preparation)
Number of subjects: 0